Advances made in the past year (2009) in the therapeutic approach to hypertensive heart disease, myocardial ischemia, and atrial fibrillation;Novedades en el último año en el planteamiento terapéutico de la cardiopatía hipertensiva, de la cardiopatía isquémica y de la fibrilación auricular

Revista Clinica Espanola

Volumn 210, Issue SUPPL. 1, 2010, Pages 2-11

  Aguiar Souto, P ^a   Raposeiras Roubin S ^a   Gonzalez Juanatey J R ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Atrial fibrillation; Hypertension; Ischemic heart disease; Update

Indexed keywords

ARTICLE; CARDIOLOGY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HYPERTENSION;

ATRIAL FIBRILLATION; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; TIME FACTORS;

EID: 79551515865     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/S0014-2565(10)70002-3     Document Type: Article

References (25)

1. G. Mancia, B.G. De, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187 (Pubitemid 46924065)
2. K. Kotseva, D. Wood, B.G. De, B.D. De, K. Pyorala, and U. Keil Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
3. V. Bertomeu, A. Cordero, J. Quiles, P. Mazón, J. Aznar, and H. Bueno Control de los factores de riesgo y tratamiento de la cardiopatía isquémica: Registro TRECE Rev Esp Cardiol 62 2009 807 811
4. F. Boutitie, F. Gueyffier, S. Pocock, R. Fagard, J.P. Boissel INDANA Project Steering Committee INdividual Data ANalysis of Antihypertensive intervention. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data Ann Intern Med 136 2002 438 448
5. S. Yusuf, K.K. Teo, J. Pogue, L. Dyal, I. Copland, and H. Schumacher Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
6. K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlof, B. Pitt, and V. Shi Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
7. H.H. Parving, F. Persson, J.B. Lewis, E.J. Lewis, and N.K. Hollenberg Aliskiren combined with losartan in type 2 diabetes and nephropathy N Engl J Med 358 2008 2433 2446
8. S.D. Solomon, E. Appelbaum, W.J. Manning, A. Verma, T. Berglund, and V. Lukashevich Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy Circulation 119 2009 530 537
9. N.S. Beckett, R. Peters, A. Fletcher HYVET Immediate benefit of treating very elderly hypertensives: results from an active-treatment extension to the Hypertension in the Very Elderly Trial (HYVET) Eur Heart J 30 Suppl 2009 860
10. A. Zanchetti, G. Grassi, and G. Mancia When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal J Hypertens 27 2009 923 934
11. R.H. Fagard, J.A. Staessen, L. Thijs, H. Celis, C.J. Bulpitt, and P.W. De Leeuw On treatment diastolic blood pressure and prognosis in systolic hypertension Arch Intern Med 167 2007 1884 1891
12. P. Sleight, J. Redon, P. Verdecchia, G. Mancia, P. Gao, R. Fagard ONTARGET investigators Prognostic value of blood pressure in patients with high vascular risk in the ongoing telmisartan alone and in combination with Ramipril Global Endpoint Trial study J Hypertens 27 2009 1360 1369
13. Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 2008 1121 1123
14. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, and J. Horrow Ticagrelor versus clopidogrel in patients with acute coronary Syndromes N Engl J Med 361 2009 1045 1057
15. D.L. Bhatt, A.M. Lincoff, C.M. Gibson, G.W. Stone, S. McNulty, G. Montalescot CHAMPION PLATFORM Investigators Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
16. N. Kukreja, P.W. Serruys, B. De Bruyne, A. Colombo, C. Macaya, G. Richardt ARTS-II Investigators Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) Heart 95 2009 1061 1066
17. R.H. Jones, E.J. Velazquez, R.E. Michler, G. Sopko, J.K. Oh, and C.M. O'Connor Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
18. M.L. O'Donoghue, E. Braunwald, E.M. Antman, S.A. Murphy, E.R. Bates, and Y. Rozenman Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a protonpump inhibitor: an analysis of two randomised trials Lancet 374 2009 989 997
19. S.R. Mehta, J.P. Bassand, S. Chrolavicius, R. Diaz, K.A. Fox, C.B. Granger CURRENT-OASIS 7 Steering Committee Design and rationale of CURRENT-OASIS 7: a randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy Am Heart J 156 2008 1080 1180
20. S. Subherwal, R.G. Bach, A.Y. Chen, B.F. Gage, S.V. Rao, and L.K. Newby Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
21. A.S. Go The ACTIVE Pursuit of Stroke Prevention in Patients with Atrial Fibrillation N Engl J Med 360 2009 2127 2129
22. The ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
23. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
24. S.H. Hohnloser, H.J. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, and C. Torp-Pedersen Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
25. J.Y. Heuzey, G. Breithardt, J. Camm, H. Crijns, P. Dorian, and P.R. Kowey The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 2010 687 693